Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20 [PMID: 22577615 DOI: 10.4292/wjgpt.v3.i2.7]
Corresponding Author of This Article
Piero Portincasa, MD, PhD, Professor, Section of Internal Medicine, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza Giulio Cesare 11, Policlinico, 70124 Bari, Italy. p.portincasa@semeiotica.uniba.it
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 Major features of the uncomplicated biliary colic
Pathogenesis
Visceral pain caused by the impaction of the stone in the cystic duct or the ampulla of Vater, followed by distension of the gallbladder and/or biliary tract with activation of visceral sensory neurons[161]
Onset
Not exclusively postprandial, typically intermittent
Intensity
Mean visual analogue scale of 9 cm on a 0-10 cm scale
Localization
Most frequently right upper quadrant of the abdomen and/or the epigastrium (representative dermatomes T8/9)
Duration
Generally longer than 15-30 min. Can last several hours and be associated non-specific symptoms of indigestion
Radiation
Angle of the right scapula and/or shoulder (about 60% of cases), retrosternal area (less than 10% of cases)
Associated features
Urgency to walk[162] (two-third of patients), nausea or vomit[42,161,162]
Relief
If the stone returns into the gallbladder lumen, passes through the ampulla of Vater into the duodenum or migrates back to the common bile duct[26]
First-line therapy
Fast-acting narcotic analgesics (meperidine[163]) or non-steroidal anti-inflammatory drugs (NSAIDs) (im or iv ketorolac or ibuprofen po) which could also reduce the risk of evolution towards acute cholecystitis[164-167]
Second-line therapy
Antispasmodic (anticholinergic) agents like hyoscine (scopolamine). Less effective than NSAIDs[164]
Recommendations
Fasting, to avoid release of endogenous cholecystokinin and further gallbladder contraction
Table 3 Indications for “prophylactic” cholecystectomy (i.e., asymptomatic gallstone patients bearing a high risk of becoming symptomatic)
Children (because they are exposed to the long-term physical presence of stones[58])
Morbid obese patients undergoing bariatric surgery (high risk to become symptomatic during rapid weight loss[62])
Patients with large gallstones (greater than 3 cm)[64,65]
A “porcelain” gallbladder[66] or gallbladder polyps rapidly growing or larger than 1 cm
Native Americans with gallstones (risk of gallbladder cancer 3 to 5 percent)[67]
Gallstone patients with sickle cell anemia (formation of calcium bilirubinate gallstones due to chronic hemolysis. Patients may become symptomatic with recurrent episodes of abdominal pain[68])
Coexistence of small gallstones and gallbladder dysmotility (increased risk of pancreatitis[47])
Table 4 Major features of the complicated biliary colic
Additional findings compared to uncomplicated biliary pain
Leukocytosis, nausea, jaundice, vomiting, fever
Underlying potential complications
Acute pancreatitis, acute cholecystitis, biliary obstruction and cholangitis, gallbladder perforation, abscess formation, mucocele of the gallbladder
Decision
Quick admission to the hospital
Therapies
Antibiotics or invasive procedures with or without surgical procedures (Figure 1)
Early laparoscopic cholecystectomy recommended between 2 and 4[168] in mild and moderate acute cholecystitis
Citation: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20